ArticleAmerican journal of clinical oncology2020

A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors.

Paul C McDonald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.